Menu
Washingtoner
  • Home
  • Health
  • Artificial Intelligence
  • Technology
  • Real Estate
  • Entertainment
  • Information Technology
  • Concealed Carry
  • Software
Washingtoner

Iohexol Injection of Beilu Pharmaceutical Receives MA in the EU
Washingtoner/10288907

Trending...
  • Spokane: Impacts For Final Stretch of Construction Season
  • Regional Magazines Shine at IRMA Awards
  • Tickeron Launches New AI Trading Robots for Semi & Finance with Profit Factor 2.8 for Hedge Funds (JPM, BAC, NVDA, GOOG, AVGO, META, AMD)
Iohexol Injection Of Beilu Pharma Receives MA Beijing Beilu Pharmaceutical Co., Ltd.
MIYUN, China - Washingtoner -- Recently, Beijing Beilu Pharmaceutical Co., Ltd. received the "Marketing Authorization" (MA) issued by the Netherlands Medicines Evaluation Board (MEB) in accordance with the relevant regulations of the European Medicines Agency.

Certificate information:
  • Company name: Beijing Beilu pharmaceutical Co., Ltd.
  • Manufacturing address: No.3 Shuiyuan West Road, Miyun District, Beijing, China
  • Registration number: RVG 132878
  • Drug name: Iohexol injection 350mg(I)/ml
  • Issuing authority: Netherlands Medicines Evaluation Board (MEB)
The successful registration of Iohexol Injection in Netherland indicates that the product has undergone rigorous scientific evaluation by EMA, confirming its compliance with EU Good Manufacturing Practice (GMP), quality, safety and efficacy standards. This authorization enables commercial distribution in EU-approved countries. It creates conditions for speeding up the Mutual recognition procedures(MRP) among EU countries such as Germany, France, Italy and others as well. This will help Beilu Pharmaceutical further promote the expansion of its overseas market and enhance the international market competitiveness of its contrast agent products, which is expected to have a positive impact on the company's operations in the future.

More on Washingtoner
  • Dr. Jay Johannigman Returns to Cincinnati Following 46 Years of Military Service
  • Spokane: Flags Will Be Lowered for Former Legislator Mike Cooper
  • Allstream Energy Partners, SEO Experts in Oil and Gas, Awarded Gas Processing OEM Agreement
  • Growth Story Expands: $54.6M Contract, $30M Revenue Run Rate, 800+ Customers, 50+ Patents & New AI Cybersecurity Products for Cycurion, Inc $CYCU
  • Sky Quarry Restarts Nevada's Only Crude Oil Refinery — A Major New Chapter Begins in This Highly Lucrative sector for N A S D A Q: SKYQ

Contact Information:
Beijing Beilu Pharmaceutical Co., Ltd.
https://www.beilupharma.com/
yanglm@beilupharma.com

Contact
Beijing Beilu Pharmaceutical Co., Ltd. 
***@beilupharma.com


Source: Beijing Beilu Pharmaceutical Co., Ltd. 
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • valueGLASS Calls for Independent Choice as Safelite Absorbs Kitsap Competitor
  • Jacqui Condon Selected to Workers' Compensation Panels for Three Professional Athlete Associations
  • Tacoma: Community Event Funding Announced for 2027
  • New Metallized PE Film from Pregis Brings Recyclability to High-Barrier Food Packaging at Pack Expo International in Chicago
  • Transformational $104 Million Musculoskeletal Healthcare Opportunity as Expansion Strategy Accelerates for Cardiff Lexington Corp (Stock Symbol: CDIX)
  • PropAccount.com Launches Marketing Hub Within PropGenie, Giving Prop Firm Operators an Automated Marketing Team
  • Save 15 Percent Off Florida Keys Accommodations with KeysCaribbean's Advance Purchase Rate Discount
  • Woodside Rehab & Nursing Enters a New Era of Clinical Excellence and Growth
  • Thar Process Partners with French Leader ExtrateX to Bring Prep to Process-Scale SFC to Europe
  • Spokane: Convicted Felon Arrested in Vancouver After Eluding SPD Officers
  • Port St. Lucie REALTOR® Irene Pernice Earns SFR® Certification
  • AMR and UAS Take the Stage at WorldSkills Shanghai 2026
  • Volunteers Invited to Help Care for Tacoma's Parks and Natural Areas on Green Tacoma Day, October 10
  • Biophysical Therapeutics brings longevity science to skincare with its new IF1 brand
  • JoCa's Echoes of Haworth Sells Out on Opening Night in Mexico City; Artist Heads to San Luis Potosí and Miami Art Week
  • Home2 Suites by Hilton Lee's Summit, MO Opens to Guests
  • Shanghai Chengwei Semiconductor Equipment Launches High Precision Laboratory Central Gas Supply System
  • Your Local Pro Expands National Service Network to 273+ Locations Across Plumbing, Cleaning, Landscaping and Hydrovac
  • Acuvance Coker Study Finds Experience, Not Supply, Is the Biggest Advanced Practice Provider Workforce Challenge
  • Molecular Hydrogen Syngergists - Webinar by Dr. Bruce Berkowsky
_catLbl0 _catLbl1

Popular on Washingtoner

  • 3ptechies Partners with Coolmuster to Give Away Data Recovery Software Licenses - 147
  • Break the Resume Mold: Career Valet Changes How Executives Hunt for Jobs - 147
  • DuoKey launches the World's First Agentic Crypto Agility Platform - 136
  • Dr. Pen Official Introduces Advanced Microneedling Technology for Precision Skincare at Home - 113
  • Marti Reeder Ranked Among Washington State's Top Real Estate Brokers by RealTrends Verified - 105
  • Applicants Sought for Tacoma Public Library Board of Trustees
  • DAZN Review 2026: Streaming Price Worth It?
  • Parksy (parksy.com) Tackles the Most Common Parking Problem Nobody Talks About: Finding the Car Again
  • Continuous You Foundation Announces Partnership with Haawke Neural Technology
  • OneVizion Appoints Zebra Technologies CIO Matt Ausman to Board of Directors

Similar on Washingtoner

  • USA Air Management Marks 30 Years of Air Duct Cleaning in NJ Urges Homeowners to Schedule Dryer Vent Cleaning Before Heating Season
  • Dr. Jay Johannigman Returns to Cincinnati Following 46 Years of Military Service
  • Nutriband Inc. (N A S D A Q: NTRB) Breaks Into Uncharted Territory: 52-Week High Eclipsed as Shares Surge 22% —AVERSA™ Puts Investors on High Alert
  • Transformational $104 Million Musculoskeletal Healthcare Opportunity as Expansion Strategy Accelerates for Cardiff Lexington Corp (Stock Symbol: CDIX)
  • Woodside Rehab & Nursing Enters a New Era of Clinical Excellence and Growth
  • Biophysical Therapeutics brings longevity science to skincare with its new IF1 brand
  • Acuvance Coker Study Finds Experience, Not Supply, Is the Biggest Advanced Practice Provider Workforce Challenge
  • Molecular Hydrogen Syngergists - Webinar by Dr. Bruce Berkowsky
  • ClearSight Therapeutics Receives NIH SBIR Phase I Award for Conjunctivitis and EKC Research
  • Lunai Bioworks (N A S D A Q: LNAI) Takes Parkinson's Discovery to the Next Level With Exclusive Tanaist Agreement
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute